Distribution of TGF-β1 C-509T polymorphism in Thai population by Vechvongvan, Vipavee et al.
นิพนธ์ต้นฉบับ	 Original	Article
J Med Health Sci Vol. 24  No. 1  April 201728
การศึกษาการกระจายตัวของ TGF-β1 C-509T ในประชากรไทย
วิภาวี เวชวงศ์วาน  เฉลิมชนม์ สุธรรมดิเรกลาภ  อภิญญา ปทุมทอง  
อนิรุทธิ์ ลิ้มตระกูล  วรรณา ผู้มีโชคชัย  ปิยะธิดา ตั้งธีระวัฒนะ
ภาควิชาจุลชีววิทยา	คณะแพทยศาสตร์	มหาวิทยาลัยศรีนครินทรวิโรฒ
บทคัดย่อ
	 ความหลากหลายของยีน	Transforming	growth	factor	beta	1	 (TGF-β1)	C-509T	มีความสัมพันธ์กับ
ความรุนแรงของโรคและความไวต่อการเป็นโรคหลายชนิด	การศึกษาน้ีมีวัตถุประสงค์เพื่อศึกษาความหลากหลาย
ของยีน	TGF-β1	C-509T	 (rs1800469)	 ในประชากรไทย	 โดยศึกษาในคนไทยปกติจ�านวน	56	คน	 	ด้วยวิธ	ี
polymerase	chain	reaction-restriction	fragment	length	polymorphism	(PCR-RFLP)	จากการศึกษาพบ
ว่ามีความหลากหลายของ	TGF-β1	C-509T	ดังนี้	CC	12.5%,	CT	39.3%	และ	TT	48.2	%	ซึ่งความถี่จีโนไทป์เหล่า
นี้ในประชากรไทยมีค่าไม่แตกต่างจากกลุ่มประชากรจีน	 (p=0.390),	อิตาลี	 (p=0.06)	 เซอเบียร์	 (p=0.55)	และ
บราซิล	 (p=0.442)	อย่างมีนัยส�าคัญทางสถิติ	แต่พบว่ามีความแตกต่างจากประชากรอินเดีย	 (p=0.005)	รัสเซีย	
(p=0.048)	อังกฤษ	(p=0.006)	เยอรมนี	(p=0.014)	และอียิปต์	(p<0.0001)	อย่างมีนัยส�าคัญทางสถิติ		เมื่อศึกษา
ความถี่ของอัลลีล	C	และ	T	พบว่า	อัลลีลที่พบมากในประชากรไทยคือ	T	ในขณะที่ในประชากรอื่นๆ	พบอัลลีล	C	
มากกว่า	(p<0.05)	การศึกษานี้น่าจะบ่งชี้ให้เห็นว่าความหลากหลายของยีน		TGF-β1	C-509T	ในประชากรไทยมี
ความแตกต่างจากประชากรกลุ่มอื่น	และอาจน�าข้อมูลนี้ไปใช้ในการพัฒนาการพยากรณ์โรคหรือการรักษาโรคได้ต่อ
ไปในอนาคต	อย่างไรก็ตามการศึกษาความหลากหลายของยีน	 เพื่อเป็นการยืนยันผลการศึกษาในครั้งน้ีควรท�าการ
ศึกษาในกลุ่มตัวอย่างที่มีขนาดใหญ่ขึ้นต่อไป
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Abstract
	 Transforming	growth	factor	beta	1	(TGF-β1)	C-509T	gene	polymorphism	has	been	found	to	
be	associated	with	severity	and	susceptibility	of	many	diseases.	To	examine	the	distribution	of	
TGF-β1	C-509T	(rs1800469)	gene	polymorphism	in	Thai	population,	56	samples	from	unrelated	
healthy	Thai	volunteers	were	analyzed	by	using	polymerase	chain	reaction-restriction	fragment	
length	polymorphism	 (PCR-RFLP)	method.	 The	 genotype	 frequencies	 of	 TGF-β1	C-509T	
polymorphisms	were	as	follows:	CC	12.5%,	CT	39.3%	and	TT	48.2%,	which	showed	no	statistically	
significant	differences	to	those	of	Chinese	(Han)	(p=0.390),	Italian	(p=0.057),	Serbian	(p=0.554)	and	
Brazilian	 (p=0.442)	population.	However,	 a	 statistically	 significant	difference	was	observed	
between	the	genotype	frequencies	 found	 in	this	study	and	those	of	 Indian	 (p=0.005),	Russian	
(p=0.048),	English	(p=0.006),	German	(p=0.014),	and	Egyptian	(p<0.0001)	population.	In	addition,	
statistically	 significant	differences	were	also	observed	between	allele	 frequencies	 in	Thai	
population	 in	this	study	and	those	of	other	 reported	groups;	 including,	Chinese	(Han),	 Indian,	
Russian,	 Italian,	English,	German,	Serbian,	Egyptian,	and	Brazilian	 (p<0.05).	The	frequency	of	T	
allele	in	Thai	was	significantly	higher	than	that	of	C	allele,	whereas	in	other	reported	groups,	the	
C	allele	frequencies	were	significantly	higher	than	T	allele	frequencies	(p<0.05).	From	the	above	
data,	it	is	likely	that	the	distribution	of	TGF-β1	C-509T	gene	polymorphisms	in	Thai	population	is	
different	from	those	of	Asian,	Caucasian,	Egyptian,	and	Brazilian	population.	This	observation	may	
be	useful	and	could	be	applied	for	treatment	and	prognostic	of	disease	in	the	future.	However,	
further	studies	in	larger	numbers	of	Thai	subjects	are	required	for	confirmation.		
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Introduction
 Transforming	 growth	 factor	 beta	 1	
(TGF-β1),	 a	multifunctional	 cytokine,	 is	 a	
member	of	 the	 transforming	 growth	 factor	
beta	superfamily1.	Mainly,	TGF-β1	protein	has	
been	 associated	 with	 cell	 growth,	 cell	
prol i ferat ion, 	 cel l 	 d i f ferent iat ion	 and	
apoptosis2-5	 leading	 to	 regulation	of	 tissue	
repair	 and	extracellular	matrix	production.	
TGF-β1	can	be	found	throughout	the	body	and	
plays	a	role	in	almost	every	biological	process,	
including	 the	development	before	birth,	 the	
formation	of	blood	vessels,	 the	regulation	of	
muscle	 tissue,	 the	development	of	body	 fat	
and	wound	healing4.	In	 immunity,	TGF-β1	has	
an	important	role	in	modulating	immunity6.
	 From	 the	 earlier	 evidence,	 TGF-β1	
was	associated	with	fibrosis	development7,8,	
s t imu l a t i n g 	 o f 	 c o l l a g e n - p r odu c i n g	
cardiomyofibroblast	 in	 heart	 fibrosis9	 and	
inducing	 or	 facilitating	 vascular	 stenosis	
and	 thrombogenesis10.	Moreover,	 TGF-β1	
was	 involved	 in	pathologic	 states	 such	 as	
inflammation	processes,	atherosclerosis,	and	
restenotic	 lesions11.	TGF-β1	was	also	 found	
to	possibly	be	a	critical	 risk	 factor	of	genetic	
susceptibility	 to	cerebral	 infarction12	and	one	
of	the	most	promising	candidates	for	chronic	
obstructive	 pulmonary	 disease	 (COPD)13.	
However,	increase	in	the	levels	of	TGF-β1	was	
seen	with	 reduced	 risk	of	Graft-versus-host-
disease	(GVHD)14.
	 The	 TGF-β1	 gene	 is 	 located	 on	
chromosome	19	 (q13.1-13.3).	Six	commonly	
known	polymorphisms	were	found	within	this	
gene,	 including	C-988A	 (rs1800820),	G-800A	
(rs1800468),	 C-509T	 (rs1800469),	 T-869C	
(rs1982073),	G-915C	(rs1800471),	and	C-11929T	
(rs1800472)15-17.	A	 number	 of	 studies	 have	
been	 attempted	 to	 determine	 whether	
natural ly 	 occur r ing	 s ing le-nucleot ide	
polymorphisms	 (SNPs)	 in	 the	TGF-β1	 gene	
af fect	 TGF-β1	 express ion	 and	 TGF-β1	
production16.	A	C-to-T	SNP	at	position	 -509	
relative	to	the	first	major	transcription	starting	
site	(rs1800469)	was	found	to	be	differentially	
related	with	transcription	factor	binding	to	the	
TGF-β1	 C-509T	 promoter,	 transcriptional	
activity	 of	 TGF-β1,	 and	 TGF-β1	 plasma	
concentration16,18.		
	 Recently,	TGF-β1	C-509T	polymorphism	
has	been	 implicated	 in	 several	diseases	 in	
different	population,	for	example:	myocardial	
infarction	 (MI)	 in	German	white	population3	
and	 young	 Italian	 population19, 	 asthma	
occurrence	 in	American,	 Indian	and	Chinese	
adults18,20,21,	modulation	of	asthma	severity	in	
Brazilian22,	as	well	as	rheumatic	heart	disease	
(RHD)	 in	Taiwanese23.	The	exploration	of	 the	
distribution	of	TGF-β1	C-509T	polymorphism	in	
Thai	population	 is	 limited.	So	 far	only	one	
study	has	been	 reported	 that	 the	genotype	
frequency	 of	 CC	was	 revealed	 separately,	
while	 those	of	CT	and	TT	were	 reported	 in	
combination	(CT+TT)24.	Therefore,	to	get	more	
information	 about	 genotype	 frequency	of	
TGF-β1	 C-509T	 polymorphisms	 in	 Thai	
population,	the	present	study	was	undertaken	
to	 identify	 the	distribution	of	CC,	CT	and	TT	
genotype	 frequencies	 separately	 in	healthy	
unrelated	Thai	 individuals.	Additionally,	 the	
TGF-β1	C-509T	genotype	and	allele	frequencies	
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in	Thai	population	were	compared	to	those	of	
previously	reported	groups.	
Objectives
	 1.	 To	 identify	 the	 TGF-β1	 C-509T	
polymorphism	 in	 healthy	 unrelated	 Thai	
individuals.
	 2.	 To	compare	TGF-β1	C-509T	genotype	
and	allele	frequencies	of	Thai	population	with	
data	from	other	published	population.
Materials and Methods
Subjects 
	 Gene	polymorphisms	were	analyzed	in	
56	healthy	unrelated	people,	 including	staffs	
and	 students	 of	 Faculty	 of	 Medic ine,	
Srinakarinwirot	University.	These	volunteers	
had	no	history	or	 sign	of	 immunodeficiency	
diseases.	 This	 study	was	 approved	by	 the	
Faculty	of	Medicine	Srinakharinwirot	University	
Ethical	Review	Committee	and	all	 subjects	
g a v e 	 w r i t t e n 	 i n f o r m e d 	 c o n s e n t	
(SWUEC/E-026/2558).
DNA Extraction
	 Five	microliters	of	saliva	were	collected	
in	 tubes.	Genomic	DNA	was	extracted	 from	
saliva	using	a	commercial	extraction	kit	(Roche,	
Germany)	 according	 to	 the	manufacturer’s	
instructions.	After extraction,	DNA	was	stored	
at	-20°C	until	analysis.
Genotyping
	 Genotyping	was	 carried	out	by	using	
polymerase	chain	reaction-restriction	fragment	
length	polymorphism	(PCR-RFLP)	technique	as	
previous	 report25.	 	Briefly,	 to	determine	 the	
genotype	of	the	TGF-β1	C-509T	polymorphism,	
PCR	was	done	using	the	forward	primer	(5′-GTC	
CCT	CTG	GGC	CCA	GTT	TC-3′)	and	the	reverse	
primer	 (5′-GAG	 GGG	 GCA	 ACA	 GGA	 CAC	
CTT A-3′).	Amplification	was	performed	 in	a	
8	µL	 reaction	mix	 containing	 0.1-1	 µg	 of	
genomic	DNA,	10	µM	of	each	oligonucleotide	
primer,	 2.5	mM	each	deoxyribonucleotide	
triphosphates	 (dNTPs),	and	2.5	units	of	 i-Taq	
DNA	polymerase	 (iNtRON	Master	Mix,	Korea).	
Amplification	conditions	were	as	 follows:	an	
initial	activation	step	of	94°C	for	2	min	followed	
by	34	cycles	of	denaturation	at	94°C	for	20	s,	
annealing	at	62°C	for	10	s,	extension	at	72°C	
for	30	s,	and	a	final	extension	step	at	72°C	for	
5	min.	After	amplification,	 the	PCR	products	
were	digested	at	37	°C	with	five	units	of Afl II	
restriction	enzyme	(New	England	Biolabs,	USA)	
for	1	hour.	DNA	fragments	were	analyzed	by	
3%	agarose	gel	containing	ethidium	bromide.
	 The	interpretations	were	as	follows:	the	
presence	 of	 TGF-β1	 C-509T	 allele	 was	
represented	by	178	bp	product,	while	 the	
presence	of	TGF-β1	C-509T	allele	was	detected	
as	159	and	19	bp	fragments.	However,	the	19	
bp	fragment	could	not	be	seen	in	the	agarose	
gel	because	of	 its	 small	 size	 (Figure	1)	The	
samples	were	 tested	 in	duplicate,	 and	 the	
results	were	100	percent	concordant.
Statistical analysis
	 Allele	and	genotype	frequencies	were	
calculated.	The	statistical	significance	of	 the	
difference	was	tested	by	chi-square	test. The	
p<0.05	were	considered	statistically	significant.	
J Med Health Sci Vol. 24  No. 1  April 201732
Statistical	analysis	was	performed	using	 the	
Vassarstats26.		
Results
	 The	 genotype	distribution	of	TGF-β1	
C-509T	 (rs1800469)	was	consistent	with	 the	
assumption	of	Hardy-Weinberg	 equilibrium	
(data	 not	 shown).	 From	 this	 study,	 the	
genotype	frequencies	of	3	genotypes:	CC,	CT	
and	TT	of	TGF-β1	C-509T	polymorphisms	were	
12.5%,	39.3%	and	48.2%,	 respectively.	The	
frequency	of	CC	genotype	was	 found	 to	be	
lower	 than	 those	 of	 CT	 and	 TT	 in	 this	
population,	 which	 differed	 from	 other	
published	 data	 where	 the	 TT	 genotype	
frequencies	were	 lower	 than	 CT	 and	 CC	
genotype	frequencies.	The	allele	frequency	of	
C	and	T	were	32.1%	and	67.9%,	respectively.
	 When	genotype	 frequencies	 from	this	
study	were	 compared	with	 those	of	other	
populations,	 no	 statist ically	 significant	
differences	with	 data	 from	Chinese	 (Han)	
(p=0.390),	Italian	(p=0.057),	Serbian	(p=0.554),	
and	Brazilian	 (p=0.442)	were	 seen,	whereas	
statistically	significant	differences	were	seen	in	
data	from	Indian	(p=0.005),	Russian	(p=0.048),	
English	(p=0.006),	German	(p=0.014),	Egyptians	
(p<0.001).	 In	contrast,	when	compared	allele	
frequencies	 from	 this	 study	 with	 other	
published	 data,	 statist ically	 significant	
differences	were	 found	with	 all	 previously	
reported	groups	(p<0.05).	(Table	1.	and	2.)
Discussion
	 This	study	aimed	to	explore	the	SNPs	of	
TGF-β1	C-509T	in	Thai	population.	The	major	
findings	of	our	study	were	as	 follows:	 (1),	All	
types	of	genotypes	(CC,	CT	and	TT)	were	seen	
Table 1 Distribution	of	TGF-β1	C-509T	gene	
polymorphism:The	 genotype	 and	
allele	 frequencies	 in	56	unrelated	
healthy	Thai	individuals.
Genotype n (%)
CC 7	(12.5%)
CT 22	(39.3%)
TT 27	(48.2%)
Allele n (%)
C 36	(32.1%)
T 76	(67.9%)
Figure 1 3%	agarose	gel	with	EtBr	electrophoresis	
of	TGF-β1	C-509T	polymorphism
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Table 2 Genotype	and	allele	frequencies	of	the	TGF-β1	C-509T	gene	polymorphism	in	healthy	
Thai	individuals	compared	with	data	from	other	groups
Genotype/
Allele
Thai
	n=56
n(%)
Chinese	
n=1015
n(%)
Indian	
n=100
n(%)
Russian	
n=212
n(%)
English	
n=2143
n(%)
Italian	
n=201
n(%)
German	
n=1211	
n(%)
Serbian	
n=49	
n(%)
Egyptian	
n=40	
n(%)
Brazilian
n=202
n(%)
References This	study [27] [28] [29] [29] [29] [29] [30] [31] [22]
Genotype
CC 7(12.5) 284(27.9) 52(52) 90(42.4) 1090(50.9) 80(39.8) 564(46.6) 13(26.5) 33(82.5) 58(28.7)
CT 22(39.3) 508(50.1) 42(42) 103(48.6) 885(41.3) 92(45.8) 508(41.9) 27(55.1) 4(10) 112(55.4)
TT 27(48.2) 223(22.0) 6(6) 19(9) 168(7.8) 29(14.4) 139(11.5) 9(18.4) 3(7.5) 32(15.8)
p-value* 0.390 0.005 0.048 0.006 0.057 0.014 0.554 <0.001 0.442
Allele
C 36(32.1) 1076(53.0) 146(73) 283(66.8) 3065(70.1) 272(67.7) 1636(67.6) 53(54.1) 70(87.5) 228(56.4)
T 76(67.9) 954(47.0) 54(27) 141(33.2) 1309(29.9) 130(32.3) 786(32.4) 45(45.9) 10(12.5) 176(43.6)
p-value* 0.004 <0.001 <0.001 <0.001 <0.001 <0.001 0.003 <0.001 0.001
*Chi-square	test	was	used	for	the	analysis	(calculated	from	the	percentage).
in	 Thai	 population,	which	were	 similar	 to	
previous	reports.	(2),	The	genotype	frequencies	
between	Thais,	and	 Indian,	Russian,	English,	
German,	 Egyptian	 population	 revealed	
statistically	 significant	differences.	 (3),	 The	
genotype	 frequencies	 between	 Thai,	 and	
Chinese	 (Han),	 Italian,	 Serbian,	 Brazilian	
population	revealed	no	statistically	significant	
difference.
	 TGF-β1	C-509T,	promoter,	 located	on	
19th	chromosome	plays	a	role	in	transcription	
starting	site	of	TGF-β1	gene.	The	polymorphism	
of	this	region	can	cause	3	types	of	genotypes	
as	follows:	CC,	CT,	and	TT.	This	polymorphism	
has	 been	 found	 to	 influence	 the	 TGF-β1	
production	 levels,	affecting	 the	outcome	of	
immune 	 ba l ance . 	 I n 	 add i t i on , 	 t h i s	
polymorphism	has	been	 implicated	 in	many	
inflammatory	 and	 autoimmune	 diseases,	
including	 thrombogenesis14,	atherosclerosis15,	
rheumatic	heart	disease23.		
	 Statistically	 significant	 difference	 in	
allele	frequencies	in	Thai	population	in	this	study	
compared	with	previous	 reports	 in	 several	
populations22,27-31	was	noted,	which	 revealed	
that	the	C	allele	frequency	in	Thai	population	
in	this	study	was	lower	than	T	allele	frequency.	
While	in	other	population	the	C	allele	frequencies	
were	higher	 than	T	 allele	 frequencies.	 For	
genotype	frequency,	the	CC	genotype	found	at	
12.5%	in	Thai	population	of	this	study	was	the	
lowest	and	is	consistent	with	the	earlier	study	
(4.2%)24.	However,	 the	genotype	 frequencies	
of	CT	and	TT	could	not	be	compared	with	
data	from	this	earlier	study	since	the	frequencies	
of	CT	and	TT	were	 reported	 in	combination	
(CT+TT),	instead	of	separately	as	in	this	study.	
The	TT	genotype	frequency	of	this	study	was	
the	 highest	 (48.2%),	 followed	 by	 the	 CT	
genotype	 frequency	 (39.3%).	 In	addition,	we	
found	 that	 the	 TGF-β1	 C-509T	 genotype	
frequencies	 in	Thai	population	were	similar	to	
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those	of	Chinese	 (Han),	 Italian,	 Serbian	and	
Brazilian	population,	but	were	different	 from	
those	of	Indian,	Russian,	English,	German	and	
Egyptian	population.	Earlier	 studies	 reported	
the	ethnic	difference	in	distribution	pattern	of	
TGF-β1	C-509T	gene	polymorphism	and	 the	
severity	and	susceptibility	of	many	diseases.	
Therefore,	 the	 polymorphism	 of	 TGF-β1	
C-509T	gene	observed	 in	Thai	population	 in	
this	study	may	be	used	potentially	as	genetic	
prediction	of	disease	susceptibility	or	clinical	
outcome	of	diseases	 in	 the	 future.	However	
for	more	 information,	 the	 study	with	 larger	
sample	size	would	be	needed.
Conclusion
	 This	 study	 showed	 that	3	 genotypes	
(CC,	CT,	and	TT)	of	TGF-β1	C-509T	polymorphisms	
were	 found	 in	 Thai	 population.	 The	 TT	
genotype	 showed	 the	 highest	 frequency	
(48.2%),	 followed	 by	 CT	 (39.3%)	 and	 CC	
genotype	 (12.5%).	The	C	allele	 frequency	of	
Thai	 population	was	 lower	 than	 T	 allele	
frequency.	These	polymorphisms	may	affect	
the	 level	of	TGF-β1	production	 in	different	
individuals.	Further	 investigation	 is	underway	
to	 elucidate	 the	 role	 of	 TGF-β1-C-509T	
promoter	polymorphism	 in	 susceptibility	 to	
various	diseases.
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